April 1, 2020 | Health Care Marketing Neuraxpharm has entered into an agreement with Panaxia Labs Israel to distribute and market medical cannabis products in
April 2, 2020 | Yahoo Finance Proceeds include a unilateral option for the investment of 6 million ILS by the company’s controlling shareholders and additional